The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce its collaboration with the California ...

Los Angeles, CA – November 14, 2025 -   The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce its ...

Members of the TAHRIR Coalition met in the Duderstadt Center to participate in their first “study-in” on North Campus ...

Cancer often infiltrates a person’s life long before anyone knows it. By the time symptoms arise and an examination indicates ...

Tāmaki Makaurau Auckland’s leadership in biomedical science and engineering has secured the city as host for the 30th Annual ...

Tissue-engineered and chip-based models are changing how scientists study early cancer, leading to more accurate and humane ...

First company to enable precision in vivo genome engineering, combining both cell-specific delivery and programmable, locus-specific gene insertion, with the potential to achieve physiological, durabl ...

University of Texas at Dallas researchers have developed biosensor technology that when combined with artificial intelligence ...

BMES looks for a chapter that demonstrates “they are second to only one” as well as strong growth, initiatives, and opportunities.

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and ...